Tvardi Therapeutics TVRD 深 沪
等待开盘 10-13 09:30:00 美东时间
1.06
+0.030
+2.91%
华盛通- 最 高1.08
- 今 开1.02
- 成交量 24.79万股
- 最 低 0.97
- 昨 收 1.03
- 总市值 1413.93万
- 52周最高 6.43
- 市盈率 静 --
- 换手率 1.86%
- 52周最低 0.93
- 委 比 -80.54%
- 总股本 1333.89万
- 历史最高 1067.292
- 量 比 1.71
- 振 幅 10.68%
- 历史最低 0.93
- 每 手 1
- 风险率 2.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tvardi Therapeutics Announces Publication Of Preclinical Data Evaluating Its STAT3 Inhibitor In International Journal Of Molecular Sciences
In a preclinical chronic colitis model, Tvardi’s oral small molecule accumulated in the colon at approximately 8-fold higher concentrations than in plasma, at pharmacologically relevant levels, and modulated STAT3-driven disease biology Collective findings now span multiple preclinical models of UC...
09-24 20:04
New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)
Tvardi Therapeutics announced the publication of preclinical data in *International Journal of Molecular Sciences* evaluating their STAT3 inhibitor TTI-101 in a chronic colitis model. The study demonstrated high colon exposure, normalization of STAT3-regulated gene expression, and prevention of colon polyps and adenocarcinomas. These findings support the potential of STAT3 inhibition in treating ulcerative colitis (UC) by targeting immune dysregu...
09-24 12:00
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes
Kura Oncology launched Caspian Therapeutics, a separately financed subsidiary focused on developing small-molecule menin inhibitors for diabetes and cardiometabolic diseases. Caspian secured $50 million in financing led by BVF Partners, with participation from T1D Fund, Eli Lilly, and others. The company will advance KO-7246, a next-generation menin inhibitor, through clinical proof of concept. Preclinical studies demonstrate KO-7246's potential ...
09-09 11:00
Tvardi Therapeutics to Participate in Upcoming Investor Events
Tvardi Therapeutics announced its participation in upcoming investor events: the Wells Fargo 21st Annual Healthcare Conference on September 9 in Boston, the 2026 Cantor Global Healthcare Conference on September 10 in New York, and the H.C. Wainwright 28th Annual Global Investment Conference on September 14 in New York. The company focuses on developing oral STAT3 inhibitors for inflammatory and proliferative diseases. TTI-109, a prodrug of TTI-10...
08-26 12:00
Tvardi Therapeutics Q2 EPS $(0.69) Beats $(0.70) Estimate
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(0.70) by 1.43 percent. This is a 31 percent increase over losses of $(1.00) per share from the same period last year.
08-14 19:07
Tvardi Therapeutics To Host KOL Webinar On August 19 To Discuss Current Treatment Landscape In Ulcerative Colitis And Persistent Unmet Needs; Event To Feature New Data From Tvardi And Review Of Phase 1 Healthy Volunteer Results Supporting Potential Of TTI-109 In UC
Tvardi Therapeutics, Inc. ("Tvardi" or the "Company") (NASDAQ:TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that it will host a KOL webinar on Wed...
08-12 20:04
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
BTIG Maintains Buy on Tvardi Therapeutics, Lowers Price Target to $5
BTIG analyst Julian Harrison maintains Tvardi Therapeutics (NASDAQ:TVRD) with a Buy and lowers the price target from $15 to $5.
07-31 03:05
美股大行评级 | 潜在涨幅215.37%！摩根士丹利上调TeraWulf(WULF)目标价至72美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从66.5美元升至72美元；HC Wainwright & Co.：维持Vera Therapeutics"买入"评级，目标价从110美元升至125美元
07-09 12:35
美股夜盘 | Republic Power涨38.76%，巨龙在线涨22.55%
Tvardi Therapeutics Inc.涨-10.80%；Dreamland涨-9.80%；有信科技涨-9.33%
07-09 08:05
